menu
    • menu

    Company profile for Knight Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Knight Therapeutics Inc. (TSX:GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and distributing innovative prescription pharmaceuticals, consumer health products and medical devices in Canada and select international markets. In addition, Knight invests in or finances other life sciences companies with the goal of securing product distribution rights. Knig...
    Knight Therapeutics Inc. (TSX:GUD) is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and distributing innovative prescription pharmaceuticals, consumer health products and medical devices in Canada and select international markets. In addition, Knight invests in or finances other life sciences companies with the goal of securing product distribution rights. Knight has acquired or in-licensed a portfolio of over 20 products that are marketed, under regulatory review or in various stages of development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Knight TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Knight Therapeutics Inc. 3400 de Maisonneuve W. Suite 1055 Montreal, QC Can...
    Telephone
    Telephone
    (514) 484-4483
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gud-knight.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/knight-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Profound Medical Reclaims TULSA-PRO Distribution In Canada
    Profound Medical Reclaims TULSA-PRO Distribution In Canada

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185091/33471/en/Profound-Medical-Regains-Exclusive-Distribution-Rights-for-TULSA-PRO-in-Canada-from-Knight.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    60 Degrees Closes 1.043M Direct Offering At-The-Market
    60 Degrees Closes 1.043M Direct Offering At-The-Market

    30 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/30/3018359/0/en/60-Degrees-Pharma-Announces-Closing-of-1-043-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    30 Jan 2025
    Share Share
    Knight Announces Closing of Previously Announced Acquisition
    Knight Announces Closing of Previously Announced Acquisition

    26 May 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/05/26/2236903/0/en/Knight-Therapeutics-Announces-Closing-of-Previously-Announced-Acquisition-and-Exclusive-License-to-Exelon-in-Canada-and-Latin-America.html#:~:text=(TSX%3A%20GUD)%20(%22,as%20well%20as%20an%20exclusive

    GLOBENEWSWIRE
    26 May 2021
    Share Share
    Knight Therapeutics to Acquire Regional Rights to Exelon®
    Knight Therapeutics to Acquire Regional Rights to Exelon®

    23 Apr 2021

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2021/04/23/2215925/0/en/Knight-Therapeutics-to-Acquire-Regional-Rights-to-Exelon.html

    GLOBENEWSWIRE
    23 Apr 2021
    Share Share
    Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™
    Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™

    01 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/03/02/2184801/0/en/Knight-Therapeutics-Announces-Canadian-Commercial-Launch-of-IBSRELA-New-Innovative-Treatment-for-Irritable-Bowel-Syndrome-with-Constipation.html

    GLOBENEWSWIRE
    01 Mar 2021
    Share Share
    Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®
    Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®

    21 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200921005824/en

    BUSINESSWIRE
    21 Sep 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search